Repositioning Ku70 unlocks cGAS–STING immunity in colorectal cancer
Acta Pharmaceutica Sinica B · 2026-08 · 16 (8) · 5506-5507
DOI: 10.1016/j.apsb.2026.07.036 ↗Kurz gefasst
Editorial in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-08. Verfasst von Hui Yang. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The cyclic GMP — AMP synthase (cGAS) — stimulator of interferon genes (STING) pathway provides a central link between genomic instability and antitumor immunity. Cytosolic double-stranded DNA activates cGAS to generate 2 ′ ,3 ′ -cyclic GMP — AMP (cGAMP), which engages STING and initiates TBK1 — IRF3 signaling, type I interferon production
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Institute for Translational Brain Research, Neurosurgical Institute of Fudan University, MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Zitieren
APA
Yang, H. (2026). Repositioning Ku70 unlocks cGAS–STING immunity in colorectal cancer. Acta Pharmaceutica Sinica B, 16(8), 5506-5507. https://doi.org/10.1016/j.apsb.2026.07.036
Vancouver
Yang H. Repositioning Ku70 unlocks cGAS–STING immunity in colorectal cancer. Acta Pharmaceutica Sinica B. 2026;16(8):5506-5507. doi:10.1016/j.apsb.2026.07.036
BibTeX
@article{Yang2026,
author = {Yang, Hui},
title = {Repositioning Ku70 unlocks cGAS–STING immunity in colorectal cancer},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {8},
pages = {5506--5507},
doi = {10.1016/j.apsb.2026.07.036}
}
EUVIMED